Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Clinical trial NCT05265793 · UNKNOWN
Trial details
- NCT number
- NCT05265793
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-21
- Primary completion
- 2023-03-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.